SPDR S&P China ETF (NYSEARCA:GXC) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. trimmed its position in SPDR S&P China ETF (NYSEARCA:GXC) by 81.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 786 shares of the company’s stock after selling 3,398 shares during the period. JPMorgan Chase & Co.’s holdings in SPDR S&P China ETF were worth $65,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GSB Wealth Management LLC acquired a new position in shares of SPDR S&P China ETF during the 3rd quarter worth $75,000. Optimum Investment Advisors grew its stake in shares of SPDR S&P China ETF by 11.5% during the 3rd quarter. Optimum Investment Advisors now owns 1,799 shares of the company’s stock worth $148,000 after purchasing an additional 185 shares during the period. Mittelman Wealth Management grew its stake in shares of SPDR S&P China ETF by 60.4% during the 3rd quarter. Mittelman Wealth Management now owns 12,441 shares of the company’s stock worth $1,022,000 after purchasing an additional 4,687 shares during the period. Summit Trail Advisors LLC grew its stake in shares of SPDR S&P China ETF by 1.5% during the 3rd quarter. Summit Trail Advisors LLC now owns 16,466 shares of the company’s stock worth $1,352,000 after purchasing an additional 240 shares during the period. Finally, Banco Santander S.A. acquired a new position in shares of SPDR S&P China ETF during the 3rd quarter worth $3,132,000.

SPDR S&P China ETF Stock Down 0.6 %

NYSEARCA:GXC opened at $77.06 on Tuesday. The stock has a market cap of $512.45 million, a PE ratio of 9.52 and a beta of 0.84. SPDR S&P China ETF has a fifty-two week low of $59.53 and a fifty-two week high of $97.17. The firm’s fifty day simple moving average is $76.31 and its 200-day simple moving average is $74.67.

About SPDR S&P China ETF

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.